IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 162 filers reported holding IMMUNOGEN INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $418,000 | -71.0% | 87,428 | -72.7% | 0.01% | -76.3% |
| Q2 2022 | $1,441,000 | -47.3% | 320,147 | -44.3% | 0.04% | -40.6% |
| Q1 2022 | $2,735,000 | -32.0% | 574,669 | +6.0% | 0.06% | -4.5% |
| Q4 2021 | $4,024,000 | +46.6% | 542,308 | +12.0% | 0.07% | +48.9% |
| Q3 2021 | $2,744,000 | +8.2% | 483,990 | +25.8% | 0.04% | -6.2% |
| Q2 2021 | $2,536,000 | +322.7% | 384,793 | +419.5% | 0.05% | +300.0% |
| Q1 2021 | $600,000 | -39.9% | 74,072 | -73.3% | 0.01% | -72.1% |
| Q3 2020 | $999,000 | +236.4% | 277,460 | +329.9% | 0.04% | +186.7% |
| Q2 2020 | $297,000 | +153.8% | 64,537 | +252.3% | 0.02% | +400.0% |
| Q4 2017 | $117,000 | +23.2% | 18,321 | -25.2% | 0.00% | 0.0% |
| Q1 2017 | $95,000 | +41.8% | 24,493 | -25.5% | 0.00% | +50.0% |
| Q4 2016 | $67,000 | -17.3% | 32,880 | +8.7% | 0.00% | 0.0% |
| Q3 2016 | $81,000 | -58.5% | 30,249 | -52.2% | 0.00% | -50.0% |
| Q2 2016 | $195,000 | – | 63,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |